Table 3.
Hazard ratios from Cox Proportional Hazards models comparing the association between presenting with advanced HIVa and time to and clinical outcomesa (N = 957)
Crude analysis | Adjusted analysisb | Maximally adjustedc | |||||||
---|---|---|---|---|---|---|---|---|---|
HRf | 95% CI | p-value | aHRf | 95% CI | p-value | aHRf | 95% CI | p-value | |
First VL test | 1.5 | 1.2, 2.0 | 0.001 | 1.2 | 0.9, 1.6 | 0.167 | 1.1 | 0.8, 1.5 | 0.442 |
First viral suppression | 1.3 | 1.0, 1.7 | 0.040 | 1.1 | 0.8, 1.4 | 0.562 | 1.0 | 0.8, 1.4 | 0.949 |
Death | 5.3 | 2.5, 11.2 | < 0.001 | 4.4 | 1.9, 10.2 | < 0.001 | 4.8 | 2.0, 11.6 | 0.001 |
Treatment failured | 1.3e | 0.8, 1.9 | 0.247 | 1.7 | 1.1, 2.5 | 0.017 | 1.9 | 1.2, 3.0 | 0.005 |
aDefined as presenting to care with CD4 < 200 or WHO Stage 3 and 4
bAdjusted for district, age, sex, and distance to health facility
cAdjusted for district, age, sex, distance to health facility, BMI, and method of enrollment
dTreatment failure was composite outcome that included death, loss to follow-up, or virological failure where virological failure which was defined as having a viral load ≥ 200 copies/ml among those who had previously achieved viral suppression
eProportional hazards assumption was violated for this model and the hazard ratio should be interpreted as the incidence rate ratio over the 630-day follow-up rather than an instantaneous hazard
fHR: Hazard ratio, aHR: adjusted Hazard ratio